This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Louis Boon, PhD
Chief Scientific Officer and Board Member at JJP Biologics
Speaker

Profile

Louis is the CSO and Management Board Member of JJP Biologics, an innovative new Polish Company backed by the Starak family. JJP Biologics develops the next generation of novel therapeutic biologics around personalized medicine and companion diagnostics (JJP Biologics: Overview | LinkedIn). Louis was the founder of various companies focused on the generation and development of therapeutic monoclonal antibodies, primarily in the field of cancer and inflammation. Louis is an author of over 400 publications in international scientific journals in the field of medical biotechnology and an inventor at more than 20 patent applications.

Agenda Sessions

  • Anti-CD89 Antibody for Personalized Treatment of IgA-mediated Inflammatory Disorders

    10:20